The AMT, Accuron and Tianda Pharmaceuticals-backed cancer drug developer raised half of its initial target for the offering.

Walmart invested in the e-commerce platform at a $20.8bn valuation, allowing SoftBank, Naspers and eBay to achieve billion-dollar returns.

The Tokyo Electric and Chubu Electric-backed renewable energy provider is targeting an initial $386m, though share sales could take the offering to $1bn.

CapitalG will exit the recruitment and employment review platform, which has agreed to a $1.2bn acquisition by Recruit.

UCL spinout Autolus has filed for an initial public offering on Nasdaq and plans on using the proceeds to further develop its range of cancer treatments.

Janssen Biotech has agreed to acquire NYU spinout Benevir for a total of up $1.04bn, including $140m in an upfront payment.

Industrial IoT platform SpaceTime Insight has been bought by Nokia for an undisclosed sum, providing exits to shareholders including Eon and NEC.

Mastercard, Intel, American Express and Santander could all exit the point-of-sale technology provider, which plans to float in Sweden.

The WuXi PharmaTech and Mayo Clinic-backed aging disease drug developer floated at the midpoint of its range.